CarciReagent Distribution s.r.o.

We have been developing and manufacturing the unique diagnostic IVD medical device for self-testing for the early detection of possible oncological disease.

CarciReagent is an IVD diagnostic medical test kit for self-testing for proof of an indicative amount of monohydroxyphenols metabolites (tyrosine) in the patient‘s urine.

Tyrosine can be used for the possible detection of malignant tumors as stomach, esophageal, colon, pancreatic, rectal, liver, cervical and breast cancer.

Our unique tester CarciReagent has significant sensitivity for malignant tumors (96,70 %) and specificity in healthy population (99,40 %).

We are looking for distributors around the world.